Latest dated submission 2026-08-03 · NDA021318
Teriparatide
26 dated AP submissions · 29 source-defined actions · 36 official documents
Open full application timeline →Exact official chronology
Drugs@FDA regulatory history
Follow FDA-coded submission dates, source-defined action labels, and direct official document links for every application in the reviewed peptide set. The chronology comes from FDA’s relational bulk tables, not title matching or generated summaries.
110Reviewed applications
1,094Dated AP submissions
1,116Action assignments
1,317Official documents
Application timelines
Browse all reviewed histories
Latest dated submission 2026-08-03 · NDA208743
Abaloparatide
11 dated AP submissions · 12 source-defined actions · 23 official documents
Open full application timeline →Latest dated submission 2026-08-03 · NDA211939
Teriparatide
4 dated AP submissions · 5 source-defined actions · 10 official documents
Open full application timeline →Latest dated submission 2026-08-03 · NDA218771
Teriparatide
3 dated AP submissions · 4 source-defined actions · 8 official documents
Open full application timeline →Latest dated submission 2026-07-01 · ANDA212972
Liraglutide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2026-06-18 · NDA215256
Semaglutide
16 dated AP submissions · 19 source-defined actions · 33 official documents
Open full application timeline →Latest dated submission 2026-06-18 · NDA218316
Semaglutide
6 dated AP submissions · 9 source-defined actions · 11 official documents
Open full application timeline →Latest dated submission 2026-06-15 · ANDA213155
Liraglutide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2026-06-02 · NDA206321
Liraglutide
20 dated AP submissions · 26 source-defined actions · 40 official documents
Open full application timeline →Latest dated submission 2026-06-01 · NDA209637
Semaglutide
14 dated AP submissions · 16 source-defined actions · 33 official documents
Open full application timeline →Latest dated submission 2026-05-21 · NDA202811
Linaclotide
20 dated AP submissions · 23 source-defined actions · 33 official documents
Open full application timeline →Latest dated submission 2026-05-06 · ANDA074728
Leuprolide
15 dated AP submissions · 14 source-defined actions · 3 official documents
Open full application timeline →Latest dated submission 2026-05-06 · ANDA075471
Leuprolide
13 dated AP submissions · 15 source-defined actions · 1 official document
Open full application timeline →Latest dated submission 2026-05-06 · ANDA078885
Leuprolide
11 dated AP submissions · 12 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2026-05-06 · ANDA212963
Leuprolide
4 dated AP submissions · 6 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2026-05-06 · ANDA213829
Leuprolide
4 dated AP submissions · 3 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2026-05-06 · ANDA215336
Leuprolide
4 dated AP submissions · 4 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2026-05-06 · ANDA215826
Leuprolide
2 dated AP submissions · 1 source-defined action · 0 official documents
Open full application timeline →Latest dated submission 2026-05-06 · ANDA217437
Leuprolide
2 dated AP submissions · 1 source-defined action · 0 official documents
Open full application timeline →Latest dated submission 2026-05-06 · ANDA217957
Leuprolide
4 dated AP submissions · 4 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2026-05-06 · NDA019010
Leuprolide
35 dated AP submissions · 34 source-defined actions · 32 official documents
Open full application timeline →Latest dated submission 2026-05-06 · NDA021343
Leuprolide
25 dated AP submissions · 24 source-defined actions · 38 official documents
Open full application timeline →Latest dated submission 2026-05-06 · NDA021379
Leuprolide
22 dated AP submissions · 21 source-defined actions · 36 official documents
Open full application timeline →Latest dated submission 2026-05-06 · NDA021488
Leuprolide
17 dated AP submissions · 16 source-defined actions · 35 official documents
Open full application timeline →Latest dated submission 2026-05-06 · NDA021731
Leuprolide
20 dated AP submissions · 19 source-defined actions · 33 official documents
Open full application timeline →Latest dated submission 2026-04-29 · BLA761412
Insulin glargine-aldy
1 dated AP submission · 0 source-defined actions · 2 official documents
Open full application timeline →Latest dated submission 2026-03-30 · ANDA212552
Liraglutide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2026-03-19 · NDA213793
Setmelanotide
6 dated AP submissions · 7 source-defined actions · 13 official documents
Open full application timeline →Latest dated submission 2026-03-12 · BLA125469
Dulaglutide
22 dated AP submissions · 24 source-defined actions · 42 official documents
Open full application timeline →Latest dated submission 2026-03-12 · BLA208471
Lixisenatide
7 dated AP submissions · 7 source-defined actions · 16 official documents
Open full application timeline →Latest dated submission 2026-03-11 · ANDA215245
Liraglutide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2026-02-25 · NDA217806
Tirzepatide
13 dated AP submissions · 21 source-defined actions · 33 official documents
Open full application timeline →Latest dated submission 2026-02-24 · ANDA217063
Liraglutide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2026-02-24 · ANDA217234
Liraglutide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2026-01-30 · NDA213051
Semaglutide
13 dated AP submissions · 18 source-defined actions · 28 official documents
Open full application timeline →Latest dated submission 2026-01-20 · NDA215866
Tirzepatide
11 dated AP submissions · 16 source-defined actions · 27 official documents
Open full application timeline →Latest dated submission 2026-01-14 · ANDA217590
Liraglutide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2025-12-12 · ANDA213641
Teriparatide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2025-12-12 · ANDA216589
Octreotide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2025-11-14 · NDA020263
Leuprolide
41 dated AP submissions · 45 source-defined actions · 48 official documents
Open full application timeline →Latest dated submission 2025-10-15 · ANDA218115
Liraglutide
2 dated AP submissions · 2 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2025-10-14 · NDA022341
Liraglutide
29 dated AP submissions · 35 source-defined actions · 52 official documents
Open full application timeline →Latest dated submission 2025-09-23 · NDA213150
Leuprolide
6 dated AP submissions · 4 source-defined actions · 13 official documents
Open full application timeline →Latest dated submission 2025-09-15 · ANDA218813
Glucagon
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2025-09-10 · NDA019943
Leuprolide
32 dated AP submissions · 31 source-defined actions · 31 official documents
Open full application timeline →Latest dated submission 2025-09-10 · NDA020011
Leuprolide
37 dated AP submissions · 36 source-defined actions · 31 official documents
Open full application timeline →Latest dated submission 2025-09-10 · NDA020708
Leuprolide
31 dated AP submissions · 30 source-defined actions · 37 official documents
Open full application timeline →Latest dated submission 2025-09-02 · NDA021773
Exenatide
36 dated AP submissions · 38 source-defined actions · 62 official documents
Open full application timeline →Latest dated submission 2025-08-27 · ANDA214568
Liraglutide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2025-08-18 · NDA019732
Leuprolide
39 dated AP submissions · 39 source-defined actions · 41 official documents
Open full application timeline →Latest dated submission 2025-08-18 · NDA020517
Leuprolide
36 dated AP submissions · 36 source-defined actions · 48 official documents
Open full application timeline →Latest dated submission 2025-07-30 · NDA201849
Glucagon
8 dated AP submissions · 9 source-defined actions · 12 official documents
Open full application timeline →Latest dated submission 2025-07-22 · ANDA214457
Glucagon
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2025-07-22 · ANDA215421
Liraglutide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2025-05-28 · NDA022200
Exenatide
31 dated AP submissions · 31 source-defined actions · 47 official documents
Open full application timeline →Latest dated submission 2025-05-28 · NDA209210
Exenatide
18 dated AP submissions · 17 source-defined actions · 39 official documents
Open full application timeline →Latest dated submission 2025-03-25 · BLA022505
Tesamorelin
12 dated AP submissions · 17 source-defined actions · 19 official documents
Open full application timeline →Latest dated submission 2025-03-17 · NDA210134
Glucagon
3 dated AP submissions · 2 source-defined actions · 7 official documents
Open full application timeline →Latest dated submission 2025-03-14 · NDA212097
Glucagon
6 dated AP submissions · 7 source-defined actions · 12 official documents
Open full application timeline →Latest dated submission 2024-12-23 · ANDA215503
Liraglutide
1 dated AP submission · 0 source-defined actions · 2 official documents
Open full application timeline →Latest dated submission 2024-12-12 · ANDA204468
Glucagon
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2024-11-19 · ANDA206697
Exenatide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2024-11-14 · NDA205054
Leuprolide
5 dated AP submissions · 5 source-defined actions · 11 official documents
Open full application timeline →Latest dated submission 2024-11-07 · ANDA211097
Teriparatide
2 dated AP submissions · 2 source-defined actions · 2 official documents
Open full application timeline →Latest dated submission 2024-11-06 · ANDA208569
Teriparatide
2 dated AP submissions · 3 source-defined actions · 1 official document
Open full application timeline →Latest dated submission 2024-11-04 · NDA214938
Vosoritide
3 dated AP submissions · 2 source-defined actions · 8 official documents
Open full application timeline →Latest dated submission 2024-10-25 · ANDA216839
Octreotide
3 dated AP submissions · 2 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2024-09-30 · ANDA216807
Octreotide
3 dated AP submissions · 2 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2024-09-27 · NDA213224
Octreotide
1 dated AP submission · 0 source-defined actions · 3 official documents
Open full application timeline →Latest dated submission 2024-09-25 · ANDA077450
Octreotide
10 dated AP submissions · 11 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2024-09-25 · ANDA077457
Octreotide
10 dated AP submissions · 10 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2024-09-16 · NDA215395
Lanreotide
3 dated AP submissions · 2 source-defined actions · 7 official documents
Open full application timeline →Latest dated submission 2024-08-12 · NDA210797
Afamelanotide
2 dated AP submissions · 1 source-defined action · 5 official documents
Open full application timeline →Latest dated submission 2024-07-11 · NDA019667
Octreotide
50 dated AP submissions · 50 source-defined actions · 29 official documents
Open full application timeline →Latest dated submission 2024-07-11 · NDA021008
Octreotide
29 dated AP submissions · 29 source-defined actions · 34 official documents
Open full application timeline →Latest dated submission 2024-07-11 · NDA022074
Lanreotide
20 dated AP submissions · 18 source-defined actions · 31 official documents
Open full application timeline →Latest dated submission 2024-07-11 · NDA208232
Octreotide
2 dated AP submissions · 2 source-defined actions · 5 official documents
Open full application timeline →Latest dated submission 2024-07-09 · ANDA203765
Octreotide
5 dated AP submissions · 5 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2024-07-09 · ANDA204669
Octreotide
5 dated AP submissions · 5 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2024-07-03 · ANDA209564
Linaclotide
4 dated AP submissions · 6 source-defined actions · 1 official document
Open full application timeline →Latest dated submission 2024-05-21 · ANDA217193
Lanreotide
1 dated AP submission · 0 source-defined actions · 1 official document
Open full application timeline →Latest dated submission 2024-05-02 · ANDA217860
Octreotide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2023-12-05 · ANDA210317
Octreotide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2023-08-08 · ANDA075957
Octreotide
8 dated AP submissions · 10 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2023-08-08 · ANDA075959
Octreotide
8 dated AP submissions · 8 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2023-03-16 · NDA021060
Ziconotide
6 dated AP submissions · 5 source-defined actions · 10 official documents
Open full application timeline →Latest dated submission 2023-02-21 · ANDA079198
Octreotide
10 dated AP submissions · 14 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2023-02-07 · ANDA209611
Linaclotide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2022-09-16 · ANDA076313
Octreotide
8 dated AP submissions · 11 source-defined actions · 1 official document
Open full application timeline →Latest dated submission 2022-09-16 · ANDA076330
Octreotide
7 dated AP submissions · 7 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2021-07-20 · NDA020918
Glucagon
24 dated AP submissions · 26 source-defined actions · 28 official documents
Open full application timeline →Latest dated submission 2021-04-13 · NDA208745
Plecanatide
6 dated AP submissions · 6 source-defined actions · 15 official documents
Open full application timeline →Latest dated submission 2021-01-26 · NDA020928
Glucagon
16 dated AP submissions · 17 source-defined actions · 12 official documents
Open full application timeline →Latest dated submission 2020-12-28 · ANDA208086
Glucagon
1 dated AP submission · 0 source-defined actions · 1 official document
Open full application timeline →Latest dated submission 2020-10-23 · NDA210557
Bremelanotide
2 dated AP submissions · 1 source-defined action · 5 official documents
Open full application timeline →Latest dated submission 2020-01-16 · NDA213182
Semaglutide
1 dated AP submission · 0 source-defined actions · 4 official documents
Open full application timeline →Latest dated submission 2019-12-18 · NDA021332
Pramlintide
11 dated AP submissions · 11 source-defined actions · 20 official documents
Open full application timeline →Latest dated submission 2019-08-27 · ANDA090834
Octreotide
3 dated AP submissions · 2 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2019-08-27 · ANDA091041
Octreotide
3 dated AP submissions · 2 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2017-06-28 · ANDA077372
Octreotide
4 dated AP submissions · 3 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2017-06-28 · ANDA077373
Octreotide
3 dated AP submissions · 2 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2011-05-11 · ANDA090985
Octreotide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2011-05-11 · ANDA090986
Octreotide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2011-01-14 · NDA021088
Leuprolide
18 dated AP submissions · 17 source-defined actions · 11 official documents
Open full application timeline →Latest dated submission 2009-10-30 · NDA021919
Exenatide
1 dated AP submission · 0 source-defined actions · 4 official documents
Open full application timeline →Latest dated submission 2008-03-04 · ANDA077329
Octreotide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2008-03-04 · ANDA077330
Octreotide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2008-03-04 · ANDA077331
Octreotide
1 dated AP submission · 0 source-defined actions · 0 official documents
Open full application timeline →Latest dated submission 2001-11-29 · ANDA075721
Leuprolide
1 dated AP submission · 0 source-defined actions · 1 official document
Open full application timeline →Latest dated submission 1998-06-26 · NDA012122
Glucagon
31 dated AP submissions · 30 source-defined actions · 0 official documents
Open full application timeline →